1. Home
  2. REKR vs ONCY Comparison

REKR vs ONCY Comparison

Compare REKR & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rekor Systems Inc.

REKR

Rekor Systems Inc.

HOLD

Current Price

$1.45

Market Cap

216.5M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.27

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REKR
ONCY
Founded
2017
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Pharmaceuticals and Biotechnology
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.5M
94.0M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
REKR
ONCY
Price
$1.45
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.00
AVG Volume (30 Days)
2.6M
1.0M
Earning Date
11-13-2025
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,028,000.00
N/A
Revenue This Year
$11.82
N/A
Revenue Next Year
$22.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.89
N/A
52 Week Low
$0.62
$0.33
52 Week High
$3.42
$1.51

Technical Indicators

Market Signals
Indicator
REKR
ONCY
Relative Strength Index (RSI) 39.00 69.09
Support Level $1.33 $0.98
Resistance Level $1.79 $1.08
Average True Range (ATR) 0.09 0.08
MACD -0.00 0.03
Stochastic Oscillator 25.27 89.74

Price Performance

Historical Comparison
REKR
ONCY

About REKR Rekor Systems Inc.

Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: